Progyny, Inc.
NASDAQ:PGNY
16.53 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 1,088.598 | 786.913 | 500.621 | 344.858 | 229.683 | 105.4 | 48.584 |
| Cost of Revenue
| 849.799 | 619.588 | 388.486 | 274.799 | 184.178 | 85.966 | 41.184 |
| Gross Profit
| 238.799 | 167.325 | 112.135 | 70.059 | 45.505 | 19.434 | 7.4 |
| Gross Profit Ratio
| 0.219 | 0.213 | 0.224 | 0.203 | 0.198 | 0.184 | 0.152 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 117.127 | 98.327 | 59.616 | 46.705 | 23.927 | 15.601 | 14.147 |
| Selling & Marketing Expenses
| 59.488 | 45.657 | 20.179 | 15.006 | 11.901 | 7.285 | 4.258 |
| SG&A
| 176.615 | 143.984 | 79.795 | 61.711 | 35.828 | 22.886 | 18.405 |
| Other Expenses
| 5.203 | 0.286 | -0.366 | 0.21 | 0 | 0 | 0 |
| Operating Expenses
| 176.615 | 143.984 | 79.795 | 61.711 | 35.828 | 22.886 | 18.405 |
| Operating Income
| 62.184 | 23.341 | 32.34 | 8.348 | 27.853 | -3.452 | -11.005 |
| Operating Income Ratio
| 0.057 | 0.03 | 0.065 | 0.024 | 0.121 | -0.033 | -0.227 |
| Total Other Income Expenses Net
| 5.203 | 1.1 | 0.095 | 0.331 | -36.41 | -2.944 | -0.714 |
| Income Before Tax
| 70.691 | 24.441 | 32.435 | 8.679 | -8.557 | -6.893 | -12.459 |
| Income Before Tax Ratio
| 0.065 | 0.031 | 0.065 | 0.025 | -0.037 | -0.065 | -0.256 |
| Income Tax Expense
| 8.654 | -5.917 | -33.334 | -37.78 | 0.012 | -1.777 | -0.003 |
| Net Income
| 62.037 | 30.358 | 65.769 | 46.459 | -8.569 | 0.661 | -12.452 |
| Net Income Ratio
| 0.057 | 0.039 | 0.131 | 0.135 | -0.037 | 0.006 | -0.256 |
| EPS
| 0.65 | 0.33 | 0.74 | 0.54 | -0.1 | 0.008 | -0.18 |
| EPS Diluted
| 0.62 | 0.3 | 0.66 | 0.47 | -0.1 | 0.008 | -0.15 |
| EBITDA
| 64.465 | 24.942 | 33.641 | 10.254 | 29.986 | 1.375 | -8.732 |
| EBITDA Ratio
| 0.059 | 0.032 | 0.067 | 0.03 | 0.131 | 0.013 | -0.18 |